PetMedix Secures $8M in Series A Funding, Paving the Way for a Strategic Alliance with Zoetis!

We are excited to announce that PetMedix has successfully raised $8,000,000 in our latest funding round, marking an important milestone in our journey toward redefining pet healthcare. This fresh infusion of capital not only reinforces our commitment to innovation and quality in the pet medicine space but also serves as a catalyst for a strategic evolution in our business model. As many of our loyal customers and partners know, the PetMedix channel has long been dedicated to delivering trusted information and solutions for pet wellness. However, in an effort to expand our reach and harness greater synergies in the market, we are joining forces with Zoetis, a global leader in animal health. While this means that the PetMedix channel will soon be discontinued, the expertise, passion, and focus on pet health you have come to value will continue to thrive under the Zoetis brand. The funds raised will be invested in facilitating a smooth transition, integrating our current services and research initiatives with Zoetis’ expansive global platform, and accelerating innovation in veterinary care. We are committed to ensuring that our community experiences enhanced value through this partnership, as Zoetis brings a wealth of resources and industry expertise to the table. For our supporters and customers, we encourage you to follow the Zoetis channels for the latest updates, news, and developments as we embark on this exciting new chapter together. We remain dedicated to advancing pet health and well-being and thank you for your continued support throughout this transformative period.